Sensormatic Electronics, LLC v. Genetec (USA) Inc.

District Court, D. Delaware·Decided September 29, 2021·No. 1:20-cv-00760·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE

SENSORMATIC ELECTRONICS, LLC, ) ) Plaintiff, ) ) v. ) C.A. No. 20-760 (MN) ) GENETEC (USA) INC. and ) GENETEC INC., ) ) Defendants. )

MEMORANDUM ORDER

At Wilmington this 29th day of September 2021: As announced at the hearing on August 10, 2021, IT IS HEREBY ORDERED that the disputed claim terms of U.S. Patent Nos. 9,463,954 (“the ’954 Patent”) and 7,307,652 (“the ’652 Patent”) are construed as follows: 1. “one or more landing matrices that define access to the floors, the access control system providing the landing matrices to the elevator controller” / “one or more landing matrices defining access to floors by one or more elevators” means “data structure(s) provided to an elevator controller that define(s) access to the floors of a building” (’954 Patent, claims 1 & 15) 2. “the landing matrices” shall be given its plain and ordinary meaning (’954 Patent, claims 1, 5, 7, 8, 9, 15, 18 & 20-25) 3. “landing matrix object” does not require construction (’954 Patent, claims 1, 4, 10-13, 15, 17, 24 & 26) 4. “landing matrix application programing interface (API)” does not require construction (’954 Patent, claims 1 & 15)1

1 The only dispute over the meaning of the terms “landing matrix object” and “landing matrix application programming interface (API)” from the ’954 Patent was whether the terms were indefinite. That is, Plaintiff proposed no construction necessary and Defendants argued the terms were indefinite. The Court found that indefiniteness had not been proven at this stage, leaving no further claim construction dispute for these terms. 5. “detecting moving objects [within said / in the] selected monitoring area” means “performing detection of moving objects only within/in said selected monitoring area” (’652 Patent, claims 1, 3 & 22) 6. Claims 9, 12 and 13 of the ’652 Patent are not invalid as indefinite for improperly mixing apparatus and method limitations under IPXL Holdings The parties briefed the issues (see D.I. 43) and submitted an appendix containing intrinsic and extrinsic evidence, including expert declarations (see D.I. 44). Each side provided a tutorial describing the relevant technology. (See D.I. 41 & 42). The Court carefully reviewed all submissions in connection with the parties’ contentions regarding the disputed claim term, heard oral argument (see D.I. 60) and applied the following legal standards in reaching its decision. I. LEGAL STANDARDS A. Claim Construction “[T]he ultimate question of the proper construction of the patent [is] a question of law,” although subsidiary fact-finding is sometimes necessary. Teva Pharms. USA, Inc. v. Sandoz, Inc., 135 S. Ct. 831, 837-38 (2015). “[T]he words of a claim are generally given their ordinary and customary meaning [which is] the meaning that the term would have to a person of ordinary skill in the art in question at the time of the invention, i.e., as of the effective filing date of the patent application.” Phillips v. AWH Corp., 415 F.3d 1303, 1312-13 (Fed. Cir. 2005) (en banc) (internal citations and quotation marks omitted). Although “the claims themselves provide substantial guidance as to the meaning of particular claim terms,” the context of the surrounding words of the claim also must be considered. Id. at 1314. “[T]he ordinary meaning of a claim term is its meaning to the ordinary artisan after reading the entire patent.” Id. at 1321 (internal quotation marks omitted). The patent specification “is always highly relevant to the claim construction analysis . . . [as] it is the single best guide to the meaning of a disputed term.” Vitronics Corp. v. Conceptronic,

Inc., 90 F.3d 1576, 1582 (Fed. Cir. 1996). It is also possible that “the specification may reveal a special definition given to a claim term by the patentee that differs from the meaning it would otherwise possess. In such cases, the inventor’s lexicography governs.” Phillips, 415 F.3d at 1316. “Even when the specification describes only a single embodiment, [however,] the claims of the patent will not be read restrictively unless the patentee has demonstrated a clear intention to limit the claim scope using words or expressions of manifest exclusion or restriction.” Hill-Rom Servs., Inc. v. Stryker Corp., 755 F.3d 1367, 1372 (Fed. Cir. 2014) (internal quotation marks omitted) (quoting Liebel-Flarsheim Co. v. Medrad, Inc., 358 F.3d 898, 906 (Fed. Cir. 2004)).

In addition to the specification, a court “should also consider the patent’s prosecution history, if it is in evidence.” Markman v. Westview Instruments, Inc., 52 F.3d 967, 980 (Fed. Cir. 1995) (en banc), aff’d, 517 U.S. 370 (1996). The prosecution history, which is “intrinsic evidence, . . . consists of the complete record of the proceedings before the PTO [Patent and Trademark Office] and includes the prior art cited during the examination of the patent.” Phillips, 415 F.3d at 1317. “[T]he prosecution history can often inform the meaning of the claim language by demonstrating how the inventor understood the invention and whether the inventor limited the invention in the course of prosecution, making the claim scope narrower than it would otherwise be.” Id. In some cases, courts “will need to look beyond the patent’s intrinsic evidence and to

consult extrinsic evidence in order to understand, for example, the background science or the meaning of a term in the relevant art during the relevant time period.” Teva, 135 S. Ct. at 841. Extrinsic evidence “consists of all evidence external to the patent and prosecution history, including expert and inventor testimony, dictionaries, and learned treatises.” Markman, 52 F.3d at 980. Expert testimony can be useful “to ensure that the court’s understanding of the technical aspects of the patent is consistent with that of a person of skill in the art, or to establish that a particular term in the patent or the prior art has a particular meaning in the pertinent field.” Phillips, 415 F.3d at 1318. Nonetheless, courts must not lose sight of the fact that “expert reports and testimony [are] generated at the time of and for the purpose of litigation and thus can suffer from bias that is not present in intrinsic evidence.” Id. Overall, although extrinsic evidence “may be useful to the court,” it is “less reliable” than intrinsic evidence, and its consideration “is unlikely to result in a reliable interpretation of patent claim scope unless considered in the context of the intrinsic evidence.” Id. at 1318-19. Where the intrinsic record unambiguously describes the scope of the patented invention, reliance on any extrinsic evidence is improper. See Pitney Bowes, Inc.

v. Hewlett-Packard Co., 182 F.3d 1298, 1308 (Fed. Cir. 1999) (citing Vitronics, 90 F.3d at 1583). B. Indefiniteness Section 112 of the Patent Act requires a patent applicant to “particularly point[] out and distinctly claim[] the subject matter” regarded as the applicant’s invention. 35 U.S.C. §

Sensormatic Electronics, LLC v. Genetec (USA) Inc., (D. Del. 2021).

Sensormatic Electronics, LLC v. Genetec (USA) Inc. (Sensormatic Electronics, LLC v. Genetec (USA) Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Warner-Jenkinson Co. v. Hilton Davis Chemical Co.
520 U.S. 17 (Supreme Court, 1997)
Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co.
535 U.S. 722 (Supreme Court, 2002)
Vitronics Corporation v. Conceptronic, Inc.
90 F.3d 1576 (Federal Circuit, 1996)
Technology Licensing Corp. v. Videotek, Inc.
545 F.3d 1316 (Federal Circuit, 2008)
Nautilus, Inc. v. Biosig Instruments, Inc.
134 S. Ct. 2120 (Supreme Court, 2014)
Hill-Rom Services, Inc. v. Stryker Corporation
755 F.3d 1367 (Federal Circuit, 2014)
Teva Pharm. United States, Inc. v. Sandoz, Inc.
135 S. Ct. 831 (Supreme Court, 2015)